pifithrin has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KC | 1 |
| MacKenzie, EM | 1 |
| Learman, CR | 1 |
| Hall, TC | 1 |
| Weaver, CL | 1 |
| Dunbar, GL | 1 |
| Song, MS | 1 |
| Luo, Y | 1 |
| Kuo, CC | 1 |
| Shen, H | 1 |
| Chou, J | 1 |
| Greig, NH | 1 |
| Hoffer, BJ | 1 |
| Wang, Y | 1 |
2 other studies available for pifithrin and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Inhibition of p53 attenuates ischemic stress-induced activation of astrocytes.
Topics: Animals; Astrocytes; Benzothiazoles; Brain Ischemia; Cell Hypoxia; Cells, Cultured; Central Nervous | 2015 |
Delayed treatment with a p53 inhibitor enhances recovery in stroke brain.
Topics: Adult Stem Cells; Analysis of Variance; Animals; Benzothiazoles; Brain; Bromodeoxyuridine; Cell Diff | 2009 |